Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx

Clinical trial NCT00211887 · COMPLETED

Trial details

NCT number: NCT00211887
Sponsor: Fred Lublin
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2005-01-01
Primary completion: 2012-04-01
Enrollment: 1008

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.